Filing Details
- Accession Number:
- 0001127602-20-023865
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-19 12:53:01
- Reporting Period:
- 2020-08-15
- Accepted Time:
- 2020-08-19 12:53:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1792150 | Merdad Parsey | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-15 | 182 | $57.43 | 182 | No | 5 | A | Direct | |
| Common Stock | Disposition | 2020-08-17 | 182 | $68.32 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 16, 2020 through August 15, 2020. This transaction is exempt under Rule 16b-3(c).
- In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's stock on February 16, 2020.
- The sale transaction reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
